BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17521383)

  • 21. Prediction of chronic allograft nephropathy using classification trees.
    Lofaro D; Maestripieri S; Greco R; Papalia T; Mancuso D; Conforti D; Bonofiglio R
    Transplant Proc; 2010 May; 42(4):1130-3. PubMed ID: 20534242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage index predicts short-term renal allograft function and graft survival.
    Srinivas TR; Kubilis PS; Croker BP
    Transpl Int; 2004 May; 17(4):195-201. PubMed ID: 15064924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
    Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
    Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cigarette smoking and chronic allograft nephropathy.
    Zitt N; Kollerits B; Neyer U; Mark W; Heininger D; Mayer G; Kronenberg F; Lhotta K
    Nephrol Dial Transplant; 2007 Oct; 22(10):3034-9. PubMed ID: 17517794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reporting the eGFR and its implication for CKD diagnosis.
    Botev R; Mallié JP
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1606-7. PubMed ID: 18922981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Ren Fail; 2008; 30(2):181-6. PubMed ID: 18300118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline in native kidney function in liver transplant recipients is not associated with BK virus infection.
    Salama M; Boudville N; Speers D; Jeffrey GP; Ferrari P
    Liver Transpl; 2008 Dec; 14(12):1787-92. PubMed ID: 19025923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.
    Minutolo R; De Nicola L; Mazzaglia G; Postorino M; Cricelli C; Mantovani LG; Conte G; Cianciaruso B
    Am J Kidney Dis; 2008 Sep; 52(3):444-53. PubMed ID: 18468747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal transplant in patients with spinal cord injuries.
    Basiri A; Shakhssalim N; Hosseini-Moghddam SM; Parvaneh MJ; Azadvari M
    Exp Clin Transplant; 2009 Mar; 7(1):28-32. PubMed ID: 19364309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How does the MDRD Study equation compare with serum creatinine in routine healthcare? Anatomy of MDRD-eGFR.
    Kallner A; Khatami Z
    Scand J Clin Lab Invest Suppl; 2008; 241():39-45. PubMed ID: 18569963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
    Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J
    Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incidence and management of anemia in renal transplantation: an observational-French study].
    Choukroun G; Deray G; Glotz D; Lebranchu Y; Dussol B; Bourbigot B; Lefrançois N; Cassuto-Viguier E; Toupance O; Hacen C; Lang P; Mazouz H; Martinez F
    Nephrol Ther; 2008 Dec; 4(7):575-83. PubMed ID: 18672417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal arterial resistance index and computerized quantification of fibrosis as a combined predictive tool in chronic allograft nephropathy.
    Pape L; Mengel M; Offner G; Melter M; Ehrich JH; Strehlau J
    Pediatr Transplant; 2004 Dec; 8(6):565-70. PubMed ID: 15598325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early identification of kidney disease by eGFR: what is the prevalence of eGFR in the population?
    Cirillo M; Lombardi C; Chiricone D; Bilancio G; Marcarelli F; De Santo NG
    J Nephrol; 2008; 21 Suppl 13():S102-6. PubMed ID: 18446741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low.
    Almond A; Siddiqui S; Robertson S; Norrie J; Isles C
    QJM; 2008 Aug; 101(8):619-24. PubMed ID: 18540009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-terminal agrin fragment--a new fast biomarker for kidney function in renal transplant recipients.
    Steubl D; Hettwer S; Vrijbloed W; Dahinden P; Wolf P; Luppa P; Wagner CA; Renders L; Heemann U; Roos M
    Am J Nephrol; 2013; 38(6):501-8. PubMed ID: 24356308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and follow-up of chronic kidney graft dysfunction: from DFG to new biomarkers].
    Mariat C
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S204-7. PubMed ID: 19000888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of BK virus replication in the first year following renal transplantation.
    Costa C; Bergallo M; Astegiano S; Terlizzi ME; Sidoti F; Segoloni GP; Cavallo R
    Nephrol Dial Transplant; 2008 Oct; 23(10):3333-6. PubMed ID: 18503098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.